BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13.01.1994

Opportunity for a License for Nonpatented Material

The Centers for Disease Control and Prevention (CDC) is offering a license for recombinant proteins and synthetic peptides to be used as immunodiagnostic reagents for detecting Hepatitis C Virus (HCV) antibodies.

Source: Federal Register — Health and Human ServicesOpen original release →